What factors determine placental transfer of drugs, and how can fetal exposure be assessed?

• A. Molecular weight alone determines placental transfer.
• B. Molecular weight, lipophilicity, ionization, and transporter involvement determine placental transfer; fetal exposure can be assessed by cord blood concentrations or PK modeling.
• C. Placental transfer is random and cannot be predicted.
• D. Only lipophilicity matters.

Answer: (B)

Placentally transferred drug exposure is governed by a combination of physicochemical properties and biological processes, not a single factor. The key determinants include molecular weight (smaller molecules cross more easily), lipophilicity (more lipophilic compounds diffuse through the placental membranes more readily), and ionization (the fraction that is non-ionized at physiological pH crosses membranes more easily). Transporter involvement matters too: active efflux or uptake by placental transporters can substantially alter transfer for many drugs. The fraction unbound in maternal plasma is also important because only the free drug can cross. All of these factors together shape how much drug reaches the fetal circulation.

For assessing fetal exposure, cord blood concentrations at birth provide a direct readout of what the fetus was exposed to up to delivery. Pharmacokinetic modeling, including physiologically based PK (PBPK) approaches, integrates maternal levels, placental transfer, fetal distribution, and clearance to estimate fetal exposure over time. Ex vivo placental perfusion studies can also quantify transfer under controlled conditions. This combination of determinants and assessment methods is why the statement that combines all these factors and assessment approaches is correct.

The other options are too simplistic: relying on molecular weight alone ignores diffusion, ionization, and transporters; claiming randomness ignores established physicochemical and biological principles; and saying only lipophilicity matters omits size, charge, and transporter effects.